We are live on ! Find out more
ACM

Altrius Capital Management Portfolio holdings

AUM $503M
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+19.46%
3 Year Est. Return
+40.58%
5 Year Est. Return
10 Year Est. Return
AUM
$428M
AUM Growth
+$16.4M
Cap. Flow
+$5.25M
Cap. Flow %
1.23%
Top 10 Hldgs %
22.52%
Holding
88
New
2
Increased
41
Reduced
37
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 17.33%
2 Consumer Staples 12.82%
3 Industrials 12.28%
4 Financials 10.94%
5 Energy 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPMD icon
76
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
$221K 0.05%
4,063
-47
-1% -$2.42K
PEG icon
77
Public Service Enterprise Group
PEG
$38.2B
$206K 0.05%
2,442
AXON
78
Axon Enterprise
AXON
$42.5B
-500
Closed -$263K
BMY icon
79
Bristol-Myers Squibb
BMY
$133B
-91,834
Closed -$5.6M
IP icon
80
International Paper
IP
$21.6B
-82,235
Closed -$4.39M
TFC icon
81
Truist Financial
TFC
$63.3B
-6,127
Closed -$252K

Similar funds

Altrius Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Altrius Capital Management held 88 positions worth $428M, up 4% from $411M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Altrius Capital Management's Q2 2025 filing shows 2 new, 41 increased, 37 reduced and 4 closed positions. Its largest new stake was Medtronic: 53,928 shares worth $4.7M. The largest sale was Bristol-Myers Squibb, an estimated $5.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Consumer Staples and Industrials.

  • Altrius Capital Management's largest Q2 2025 buy was Medtronic: 53,928 shares worth $4.7M.
  • Altrius Capital Management added most to Altrius Global Dividend ETF in Q2 2025, an estimated $2.67M increase.
  • Altrius Capital Management's biggest Q2 2025 reduction was Cardinal Health, cutting an estimated $1.49M.
  • Altrius Capital Management fully exited Bristol-Myers Squibb in Q2 2025, selling an estimated $5.6M.
  • Altrius Capital Management's ten largest holdings make up 23% of its $428M portfolio in Q2 2025.
  • Altrius Capital Management opened 2 new positions and closed 4 in Q2 2025.
  • Altrius Capital Management's portfolio value rose 4% quarter-over-quarter to $428M.

Based on Altrius Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.